TY  - GEN
AU  - Schoos,Mikkel M
AU  - De Luca,Giuseppe
AU  - Dangas,George D
AU  - Clemmensen,Peter
AU  - Ayele,Girma Minalu
AU  - Mehran,Roxana
AU  - Stone,Gregg W
TI  - Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial
SN  - 1969-6213
PY  - 2017///0726
KW  - Aged
KW  - Anticoagulants
KW  - therapeutic use
KW  - Antithrombins
KW  - Cause of Death
KW  - Drug Therapy, Combination
KW  - Female
KW  - Graft Occlusion, Vascular
KW  - epidemiology
KW  - Heparin
KW  - Hirudins
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mortality
KW  - Myocardial Infarction
KW  - Myocardial Revascularization
KW  - statistics & numerical data
KW  - Peptide Fragments
KW  - Percutaneous Coronary Intervention
KW  - methods
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Postoperative Complications
KW  - Recombinant Proteins
KW  - Recurrence
KW  - ST Elevation Myocardial Infarction
KW  - therapy
KW  - Stroke
KW  - Thrombosis
KW  - Time-to-Treatment
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.4244/EIJV12I9A186
ER  -